These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23797678)

  • 1. Is the BTS/SIGN guideline confusing? A retrospective database analysis of asthma therapy.
    Covvey JR; Johnston BF; Wood F; Boyter AC
    Prim Care Respir J; 2013 Sep; 22(3):290-5. PubMed ID: 23797678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
    Drivenes E; Ostrem A; Melbye H
    BMC Fam Pract; 2014 Mar; 15():42. PubMed ID: 24597538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.
    Rottenkolber M; Fischer R; Ibáñez L; Fortuny J; Reynolds R; Amelio J; Gerlach R; Tauscher M; Thürmann P; Hasford J; Schmiedl S
    BMC Pulm Med; 2015 May; 15():55. PubMed ID: 25943421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
    Turner S; Richardson K; Murray C; Thomas M; Hillyer EV; Burden A; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(1):99-106.e3. PubMed ID: 27421902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate asthma therapy-a tale of two countries: a parallel population-based cohort study.
    Belhassen M; Nibber A; Van Ganse E; Ryan D; Langlois C; Appiagyei F; Skinner D; Laforest L; Soriano JB; Price D
    NPJ Prim Care Respir Med; 2016 Oct; 26():16076. PubMed ID: 27735927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of asthma severity from electronic prescription records using British thoracic society treatment steps.
    Tibble H; Sheikh A; Tsanas A
    BMC Pulm Med; 2022 Nov; 22(1):397. PubMed ID: 36329425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.
    Price D; Miravitlles M; Pavord I; Thomas M; Wedzicha J; Haughney J; Bichel K; West D
    NPJ Prim Care Respir Med; 2016 Nov; 26():16061. PubMed ID: 27808096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
    Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
    BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD.
    Papala M; Kerenidi N; Gourgoulianis KI
    Prim Care Respir J; 2013 Sep; 22(3):362-4. PubMed ID: 23989678
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
    Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
    Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.
    Gruffydd-Jones K; Brusselle G; Jones R; Miravitlles M; Baldwin M; Stewart R; Rigazio A; Davis E; Keininger DL; Price D
    NPJ Prim Care Respir Med; 2016 Feb; 26():16002. PubMed ID: 28358398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Kondla A; Glaab T; Pedersini R; Lommatzsch M
    Respir Med; 2016 Sep; 118():58-64. PubMed ID: 27578472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β
    Buhl R; Heaney LG; Loefroth E; Larbig M; Kostikas K; Conti V; Cao H
    Respir Med; 2020 Feb; 162():105859. PubMed ID: 31916534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.